TY - JOUR
T1 - Complement in cancer
T2 - Untangling an intricate relationship
AU - Reis, Edimara S.
AU - Mastellos, Dimitrios C.
AU - Ricklin, Daniel
AU - Mantovani, Alberto
AU - Lambris, John D.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - In tumour immunology, complement has traditionally been considered as an adjunctive component that enhances the cytolytic effects of antibody-based immunotherapies, such as rituximab. Remarkably, research in the past decade has uncovered novel molecular mechanisms linking imbalanced complement activation in the tumour microenvironment with inflammation and suppression of antitumour immune responses. These findings have prompted new interest in manipulating the complement system for cancer therapy. This Review summarizes our current understanding of complement-mediated effector functions in the tumour microenvironment, focusing on how complement activation can act as a negative or positive regulator of tumorigenesis. It also offers insight into clinical aspects, including the feasibility of using complement biomarkers for cancer diagnosis and the use of complement inhibitors during cancer treatment.
AB - In tumour immunology, complement has traditionally been considered as an adjunctive component that enhances the cytolytic effects of antibody-based immunotherapies, such as rituximab. Remarkably, research in the past decade has uncovered novel molecular mechanisms linking imbalanced complement activation in the tumour microenvironment with inflammation and suppression of antitumour immune responses. These findings have prompted new interest in manipulating the complement system for cancer therapy. This Review summarizes our current understanding of complement-mediated effector functions in the tumour microenvironment, focusing on how complement activation can act as a negative or positive regulator of tumorigenesis. It also offers insight into clinical aspects, including the feasibility of using complement biomarkers for cancer diagnosis and the use of complement inhibitors during cancer treatment.
UR - http://www.scopus.com/inward/record.url?scp=85039035360&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039035360&partnerID=8YFLogxK
U2 - 10.1038/nri.2017.97
DO - 10.1038/nri.2017.97
M3 - Review article
AN - SCOPUS:85039035360
VL - 18
SP - 5
EP - 18
JO - Nature Reviews Immunology
JF - Nature Reviews Immunology
SN - 1474-1733
IS - 1
ER -